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ABSTRACT 
Background: One  of  the  global  targets  for  non-communicable diseases  is  to  halt,  by  
2025,  the  rise  in  the  age standardised adult prevalence of diabetes at its 2010 levels. We 
aimed to estimate worldwide trends in diabetes, how likely it is for countries to achieve the 
global target, and how changes in prevalence, together with population growth and ageing, 
are affecting the number of adults with diabetes.  
 
Methods: We pooled data from population-based studies that had collected data on diabetes 
through measurement of its biomarkers. We used a Bayesian hierarchical model to estimate 
trends in diabetes prevalence—defined as fasting plasma glucose of 7·0 mmol/L or higher, or 
history of diagnosis with diabetes, or use of insulin or oral hypoglycaemic drugs—in 200 
countries and territories in 21 regions, by sex and from 1980 to 2014. We also calculated the 
posterior probability of meeting the global diabetes target if post-2000 trends continue. 
 
Findings: We used data from 751 studies including 4 372 000 adults from 146 of the 200 
countries we make estimates for. Global  age-standardised  diabetes  prevalence  increased  
from 4·3%  (95%  credible  interval  2·4–7·0)  in  1980  to  9·0%  (7·2–11·1) in 2014 in men, 
and from 5·0% (2·9–7·9) to 7·9% (6·4–9·7) in women. The number of adults with diabetes in 
the world increased from 108 million in 1980 to 422 million in 2014 (28·5% due to the rise in 
prevalence, 39·7% due to population growth and ageing, and 31·8% due to interaction of 
these two factors). Age-standardised adult diabetes prevalence in 2014 was lowest in 
northwestern Europe and highest in Polynesia and Micronesia, at nearly 25%, followed by 
Melanesia and the Middle East and north Africa. Between 1980 and 2014 there was little 
change in age-standardised diabetes prevalence in adult women in continental western 
Europe, although crude prevalence rose because of ageing of the population. By contrast, 
age-standardised adult prevalence rose by 15 percentage points in men and women in 
Polynesia and Micronesia.  In  2014,  American  Samoa  had  the  highest  national  
prevalence  of  diabetes  (>30%  in  both  sexes), with age-standardised adult prevalence also 
higher than 25% in some other islands in Polynesia and Micronesia. If post-2000 trends 
continue, the probability of meeting the global target of halting the rise in the prevalence of 
diabetes by 2025 at the 2010 level worldwide is lower than 1% for men and is 1% for 
women. Only nine countries for men and 29 countries for women, mostly in western Europe, 
have a 50% or higher probability of meeting the global target. 
 
Interpretation: Since  1980,  age-standardised  diabetes  prevalence  in  adults  has  increased,  
or  at  best  remained unchanged, in every country. Together with population growth and 
ageing, this rise has led to a near quadrupling of the number of adults with diabetes 
worldwide. The burden of diabetes, both in terms of prevalence and number of adults 
affected, has increased faster in low-income and middle-income countries than in high-
income countries. 
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